Manzoor Ahmad Mir (Manzoor A Mir)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 16

Top Topics

Molecular Docking

Natural Killer Cells

Antimicrobial Resistance

Top Venues

Medical oncology (Northwood, London, England)

Future oncology (London, England)

Applied microbiology and biotechnology

This page only lists publications with an associated author ORCID identifier.

Publications

Mohammad Nadeem Lone, Shazia Gul, Umar Mehraj, Shazia Sofi, Abid Hamid Dar, Shabir Ahmad Ganie, Nissar Ahmad Wani, Manzoor Ahmad Mir, Mohammed A Zargar
Synthesis and Biological Evaluation of Novel Uracil Derivatives as Thymidylate Synthase Inhibitors. Applied biochemistry and biotechnology (2023)
Basharat Ahmad Bhat, Wajahat Rashid Mir, Mustfa Alkhanani, Abdullah Almilaibary, Manzoor Ahmad Mir
Network pharmacology and experimental validation for deciphering the action mechanism of Fritillaria cirrhosa D. Don constituents in suppressing breast carcinoma. Journal of biomolecular structure & dynamics (2023)
Hina Qayoom, Shazia Sofi, Manzoor Ahmad Mir
Targeting tumor microenvironment using tumor-infiltrating lymphocytes as therapeutics against tumorigenesis. Immunologic research (2023)
Hina Qayoom, Mustfa Alkhanani, Abdullah Almilaibary, Suliman A Alsagaby, Manzoor Ahmad Mir
A network pharmacology-based investigation of brugine reveals its multi-target molecular mechanism against Breast Cancer. Medical oncology (Northwood, London, England) 40 (7) (2023)
Mohd Zahoor Ul Haq Shah, Vinoy Kumar Shrivastava, Shazia Sofi, Yahya F Jamous, Mohd Faiyaz Khan, Faisal K Alkholifi, Wasim Ahmad, Manzoor Ahmad Mir
Chlorogenic Acid Restores Ovarian Functions in Mice with Letrozole-Induced Polycystic Ovarian Syndrome Via Modulation of Adiponectin Receptor. Biomedicines 11 (3) (2023)
Mohd Zahoor Ul Haq Shah, Vinoy Kumar Shrivastava, Shazia Sofi, Yahya F Jamous, Mohd Faiyaz Khan, Faisal K Alkholifi, Wasim Ahmad, Manzoor Ahmad Mir
Chlorogenic Acid Restores Ovarian Functions in Mice with Letrozole-Induced Polycystic Ovarian Syndrome Via Modulation of Adiponectin Receptor. Biomedicines 11 (3) (2023)
Bashir Ahmad Sheikh, Basharat Ahmad Bhat, Manzoor Ahmad Mir
Antimicrobial resistance: new insights and therapeutic implications. Applied microbiology and biotechnology 106 (19-20) (2022)
Manzoor Ahmad Mir, Bilkees Mir, Manoj Kumawat, Mustfa Alkhanani, Ulfat Jan
Manipulation and exploitation of host immune system by pathogenic <i>Mycobacterium tuberculosis</i> for its advantage. Future microbiology 17 (2022)
Umar Yousuf, Shazia Sofi, Aanisa Makhdoomi, Manzoor Ahmad Mir
Identification and analysis of dysregulated fatty acid metabolism genes in breast cancer subtypes. Medical oncology (Northwood, London, England) 39 (12) (2022)
Shazia Sofi, Umar Mehraj, Hina Qayoom, Shariqa Aisha, Syed Mohammad Basheeruddin Asdaq, Abdullah Almilaibary, Manzoor Ahmad Mir
Cyclin-dependent kinases in breast cancer: expression pattern and therapeutic implications. Medical oncology (Northwood, London, England) 39 (6) (2022)
Shazia Sofi, Umar Mehraj, Hina Qayoom, Shariqa Aisha, Abdullah Almilaibary, Mustfa Alkhanani, Manzoor Ahmad Mir
Targeting cyclin-dependent kinase 1 (CDK1) in cancer: molecular docking and dynamic simulations of potential CDK1 inhibitors. Medical oncology (Northwood, London, England) 39 (9) (2022)
Hina Qayoom, Umar Mehraj, Shazia Sofi, Shariqa Aisha, Abdullah Almilaibary, Mustfa Alkhanani, Manzoor Ahmad Mir
Expression patterns and therapeutic implications of CDK4 across multiple carcinomas: a molecular docking and MD simulation study. Medical oncology (Northwood, London, England) 39 (10) (2022)
Umar Mehraj, Hina Qayoom, Manzoor Ahmad Mir
Prognostic significance and targeting tumor-associated macrophages in cancer: new insights and future perspectives. Breast cancer (Tokyo, Japan) 28 (3) (2021)
Umar Mehraj, Rais A Ganai, Muzafar A Macha, Abid Hamid, Mohammed A Zargar, Ajaz A Bhat, Mohd Wasim Nasser, Mohammad Haris, Surinder K Batra, Bader Alshehri, Raid Saleem Al-Baradie, Manzoor Ahmad Mir, Nissar Ahmad Wani
The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities. Cellular oncology (Dordrecht) 44 (6) (2021)
Umar Mehraj, Abid Hamid Dar, Nissar A Wani, Manzoor Ahmad Mir
Tumor microenvironment promotes breast cancer chemoresistance. Cancer chemotherapy and pharmacology 87 (2) (2021)
Hina Qayoom, Nissar Ahmad Wani, Bader Mohammed Alshehri, Manzoor Ahmad Mir
An insight into the cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer. Future oncology (London, England) 17 (31) (2021)